Requests for Euthanasia and Assisted Suicide

NCT ID: NCT02845817

Last Updated: 2016-07-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

31 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-09-30

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study take place in the palliative care units of Burgundy-Franche-Comté regions and at the Maison Médicale Jeanne Garnier. The main aim of this project is to analyze and understand the meaning of explicit requests to hasten death (euthanasia and assisted suicide).

This involves conducting interviews with patients, carers to whom the request has been expressed and a relative chosen by the patient. This study aims to describe the request over time. This will be done through two series of interviews, one as soon as it is first expressed, then one week later.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Palliative Care End of Life Euthanasia Assisted Suicide Qualitative Research

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Qualitative research

Semi-structured interviews

Group Type OTHER

Qualitative research

Intervention Type OTHER

Semi-structured interviews

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Qualitative research

Semi-structured interviews

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult not under guardianship or curatorship,
* Hospitalized in palliative care units of Bourgogne-Franche-Comté region and in the Maison Médicale Jeanne Garnier in Paris,
* At the end of life due to advanced stage disease or a major change in the state of health of an elderly person,
* They have made an explicit request for euthanasia or assisted suicide,
* They are in capacity to meet researchers for interview,
* Having consented to interviews,
* They are covered by the French social security system.

Exclusion Criteria

* Adult under guardianship or curatorship,
* They are underage,
* They are not hospitalized in Palliative Care Unit of Bourgogne-Franche-Comté region and in the Maison Médicale Jeanne Garnier,
* The request was expressed by another person or not explicit,
* They didn't consent to interviews,
* The request appears in the context of a situation other than illness or a general change in state of health
* They are not in capacity to meet researchers for interviews.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Maison Médicale Jeanne Garnier

OTHER

Sponsor Role collaborator

Centre Hospitalier Universitaire de Besancon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Régis AUBRY, PR

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Universitaire de Besançon

Danièle LEBOUL, MCU

Role: PRINCIPAL_INVESTIGATOR

Maison Médicale Jeanne Garnier

Frédéric GUIRIMAND, DR

Role: PRINCIPAL_INVESTIGATOR

Maison Médicale Jeanne Garnier

Aline CHASSAGNE, IRC

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Universitaire de Besançon

Florence MATHIEU-NICOT, Phd

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Universitaire de Besançon

Anne BOUSQUET, Phd

Role: PRINCIPAL_INVESTIGATOR

Maison Médicale Jeanne Garnier

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHRU Besançon - Palliative Care Unit

Besançon, Bourgogne-Franche-Comté, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DESA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Responses Study
NCT04445896 COMPLETED
Cancer End Of Life Evaluation
NCT01545921 TERMINATED NA
UC Health Care Planning Study
NCT04012749 COMPLETED NA